Hemoglobin A1c

DIAGNOSTIC_TEST5 trials

Sponsors

Pacific Northwest University of Health Sciences, Methodist Health System, Ohio State University, Thomas Jefferson University, Rutgers, The State University of New Jersey

Conditions

Chronic Kidney DiseasesDiabetesDiabetes MellitusGestational DiabetesHyperglycemiaHypertensionInsulin Dependent DiabetesKidney Transplant Failure

Unknown Phase

Chronic Kidney Disease and Cardiovascular Disease Risk Assessment

WithdrawnNCT03975439

Pacific Northwest University of Health SciencesChronic Kidney Diseases, Diabetes Mellitus, Hypertension

Start: 2020-02-01End: 2020-02-05Updated: 2022-07-14

Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus

WithdrawnNCT04216303

Methodist Health SystemDiabetes, Kidney Transplant Failure, Liver Transplant; Complications

Start: 2019-09-12End: 2021-08-19Updated: 2021-09-17

Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

RecruitingNCT06184373

Ohio State UniversityGestational Diabetes, Hyperglycemia

Start: 2025-06-06End: 2027-05-30Target: 20Updated: 2026-01-22

Universal Hemoglobin A1c Versus Risk-based Screening for Early Gestational Diabetes Mellitus (EARLY GDM): A Randomized Controlled Trial

Thomas Jefferson UniversityGestational Diabetes, Large for Gestational Age

Start: 2024-01-31End: 2025-06-30Target: 770Updated: 2024-01-05

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

RecruitingNCT06899191

Rutgers, The State University of New JerseyHyperglycemia, Insulin Dependent Diabetes, Type 2 Diabetes +1

Start: 2025-03-30End: 2026-03-31Target: 200Updated: 2025-05-07